RxDoctor Payments DataLook up a doctor →

Brian Stegman, MD

Interventional Cardiology · St Cloud, MNNPI 1447425160

Payments from drug & device makers

$2,285,285in general payments, 2019–2025

Across 1,308 payments — averaging $1747.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$874K
  • Cardiovascular Systems Inc.$584K
  • Boston Scientific$433K
  • Inari Medical, Inc.$170K
  • Medtronic$107K
  • Angiodynamics, Inc.$42K
  • plus $76K from 17 others
$6,818in research payments, 2019–2025

Across 3 payments — averaging $2272.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$7K
  • Abiomed$33

What the payments were for

  • Consulting fees$228,82939%
  • Speaking & faculty fees$289,74849%
  • Travel & lodging$42,2127%
  • Food & beverage$26,3134%
  • Education$160%
  • Entertainment$470%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences450$874,172
Cardiovascular Systems Inc.90$583,593
Boston Scientific146$432,564
Inari Medical, Inc.220$169,905
Medtronic(2 entities)240$107,340
Angiodynamics, Inc.33$42,058
Abbott32$30,409
Inquis Medical, Inc.17$20,836
Abiomed44$19,382
Ancora Heart, Inc.9$2,213
Shockwave Medical, Inc7$870
ZOLL Circulation Inc2$807
Stryker1$625
Cardiac Dimensions, Inc.3$130
Reflow Medical Inc1$81
Terumo Medical Corporation4$64
Patterson Companies, Inc.1$50
Opsens Inc.1$47
Heartflow, Inc.2$36
E.r. Squibb & Sons, L.L.C.2$34
Philips North America LLC1$29
GE HealthCare1$26
Cordis US CORP.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,285,285 in reported general payments places this provider in the 95th percentile of 84 interventional cardiology providers in Minnesota.

See all interventional cardiology providers in Minnesota →

Medicare billing

Part B allowed, 2024
$191,425
Medicare patients
466
Services billed
1,346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban52$72,477
JardianceEmpagliflozin32$35,248
Repatha SureclickEvolocumab31$33,111
Metoprolol Succinate121$2,255
Atorvastatin Calcium91$1,577
Ezetimibe22$1,303
Ranolazine ErRanolazine11$872
Isosorbide Mononitrate ErIsosorbide Mononitrate38$713
Rosuvastatin Calcium56$609
Furosemide99$506
ClopidogrelClopidogrel Bisulfate37$400
Lisinopril42$380
Diltiazem 24hr Er (Cd)Diltiazem Hcl16$344
Losartan Potassium38$343
Carvedilol36$332

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in St Cloud

See the full list for Minnesota →

Where these figures come from

Is this you, or does something look wrong? →